Description
Tirzepatide 10 mg | Produced by BioPep LLC | Lot#25084
Tirzepatide is a novel, investigational peptide belonging to the dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists class. Developed for the treatment of type 2 diabetes, tirzepatide combines the actions of both GIP and GLP-1 to enhance glycemic control. It stimulates insulin release and inhibits glucagon production in response to elevated blood sugar levels, contributing to improved blood glucose regulation. Additionally, tirzepatide is designed to address weight management, as it may induce weight loss. Clinical trials have shown promising results, demonstrating its potential as an effective and well-tolerated option for test subjects with type 2 diabetes.
This PRODUCT IS FOR RESEARCH USE ONLY. This classification permits the use of research chemicals solely for in vitro testing and laboratory experiments. All information about the product provided on this website is intended for educational purposes only. Any introduction of this product into the human or animal body is strictly prohibited by law. Only licensed and qualified professionals should handle this product. It is not classified as a drug, food, or cosmetic, and must not be misrepresented, misused, or labeled as such.